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I greatly appreciate Dr Bassano and
his colleagues’ interest in our article.1
I read the results of their clinical data
with interest as well. They found a
steep increase in the rate of aortic
expansion at an aortic diameter of 50
mmwith strong statistical significance
even in the analysis on a relatively
small number of patients. This result
is quite different from that of our pre-
vious study in which no significant
correlation was found between preop-
erative aortic diameter and the aortic
expansion rate after aortic valve
replacement (AVR).1 Perhaps these
discordant results may be attributable
to differences in the patient cohorts,
but I believe they need to look back
at their data to see whether any other
plausible factors exist as confounders
(eg, connective tissue disorder)
behind their correlation.
There have been mixed conclusions
in the literature on whether to replace
amoderately dilated aorta or not during
AVR, and controversies are ongoing.2-4
Our previous study showed that AVR
alone seemed reasonable in a
moderately dilated ascending aorta
based on a low rate of clinical events
and aortic aneurysm formation as well
as the limited rate of aortic expansion,
but the study was not meant to be
conclusive; its results were believed to
be provocative of further studies to
define a more reasonable indication
for concomitant replacement of the
aorta. Safety in concomitant aortic
surgery is another issue to be
addressed. Although there was no
operative mortality among 70 patients
who underwent aorta replacement in
our series, I don’t agree that it can
be performed ‘‘without significant1440 The Journal of Thoracic andadditional risks.’’ Evaluations on tens
of patients are not enough to
determine the risk of a procedure, and
I believe that any additional procedure
always carries a certain level of risk.
What is important is how great the
risk is. Current risk calculating
systems for cardiovascular surgery,
EuroSCORE II for instance, also
consider this ‘‘additional procedure’’
as the factor that increases early
mortality calculated in a logistic
function. Because a dilated aorta is a
common finding during AVR, the
recommendations we make may
affect a huge number of patients, even
if the increased risk of concomitant
aorta surgery is small. Thus, risk-
benefit assessments on concomitant
aorta surgery should be made through
large-scale studies such asmultiinstitu-
tional registry-based analyses.
We found that the rate of aortic
expansion was 5.6  8.0 mm/y in
aortic stenosis, 2.6  5.2mm/y in
mixed stenoregurgitation, and 1.4
 4.5 mm/y in aortic regurgitation;
the differences were statistically
marginal as shown in our previous
study (P ¼ .083 using the Kruskal-
Wallis test).1 When we compared the
expansion rates only between aortic
stenosis and aortic regurgitation, the
difference was statistically significant
(P ¼ .003 using the Mann-Whitney U
test), in concordance with Dr Bassano
and colleagues’ assumption. This is an
unexpected finding in my view, and
Dr Bassano’s hypothesis may explain
the mechanism behind this phenome-
non, but other plausible mechanisms
can be speculated as well. Further
studies are also needed to address
this issue, and I believe the study
population should be extended to
those with all sizes of aorta rather
than confining it to a certain range to
reach an appropriate conclusion on
this.
Joon Bum Kim, MD, PhD
Department of Thoracic and
Cardiovascular Surgery
Asan Medical CenterCardiovascular Surgery c April 2014University of Ulsan College of
Medicine
Seoul, Korea
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We appreciate much the interest in
our report.1 The issues raised by
this letter can be summarized as
follows: (1) what was the etiology
of the tricuspid regurgitation (TR);
(2) what was the pulmonary artery
pressure (PAP) level; and (3) whether
TR associated with a left-sided car-
diac lesion will exhibit a poorer
prognosis?
With regard to the etiology of TR,
8 patients had a history of blunt
chest trauma, all of whom showed
leaflet prolapse. For these patients,
the etiology would probably fit into
‘‘traumatic’’ but that might not be
confirmative. Another 12 patients
had leaflet prolapse; however, a his-
tory of chest trauma was not evident.
This could have been, in part, because
some patients might not recall the
traumatic event that happened long
ago. Although the etiology, in these
cases, could have been degenerative
or traumatic, it would be better for it
to remain as ‘‘unknown.’’ Regarding
rheumatic involvement, the presence
Letters to the Editorof leaflet thickening might best repre-
sent rheumatic disease, which was
seen in 4 patients. Another 27 patients
had no leaflet pathologic features
(only annular dilatation with or
without tethering), and it could be
defined as ‘‘idiopathic’’ or ‘‘func-
tional.’’ As such, specifying the
etiology in every case would have
been very difficult or perhaps impos-
sible in some cases. Therefore, we
believe that describing the pathologic
features (leaflet abnormality, annular
dilatation, tethering), rather than
specifying the etiology, was a more
reasonable method.
The PAP can be estimated by the
levels of the TR pressure gradient,
which were 27.5  9.0 mm Hg
and 22.6  7.7 mm Hg for those
undergoing tricuspid valve repair
and replacement, respectively, as
described in our Table 2.1 Generally,
systolic PAP has been estimated by
this value, with 5 mm Hg added for
the estimated right atrial pressure.2
Given that patients with severe TR
tend to have a higher right atrial
pressure, the addition of 15 to
20 mm Hg might be needed in some
cases. Nevertheless, the estimated
PAP was still within normal range,
as expected, because the patients did
not have any left-sided cardiac
lesions.
Finally, regarding the influence of
PAP on the long-term outcomes in
patients with severe TR, we have tried
to address this issue by analyzing
patients with severe TR of all
etiologies and the results now
available from a published study.3
In that study, 449 patients were
included. Of these patients, 60
(13.4%) had a history of left-sided
valve surgery and 359 (80.0%)
had undergone concomitant left-
sided valve surgery. On multivariate
analysis, survival was affected by
advanced heart failure symptoms,
comorbidities, end-organ dysfunction,
and laboratory abnormalities, but not
by the type of surgery, causes of TR,
or PAP level. It is well known thatThe Journalthe preoperative PAP level is
associated with late outcomes after
left-sided valve surgery; however,
we also know that the surgical
outcomes of primary isolated TR
(with normal PAP) have also been
poor, which has been more related
to right ventricular dysfunction.
Therefore, we have assumed that the
effects of ‘‘higher PAP’’ in patients
with secondary TR and ‘‘normal
PAP’’ in those with primary TR
have been counterbalanced in the
long-term outcomes. However, we
also believe this issue should be
addressed in additional studies with
more sophisticated designs.
Joon Bum Kim, MD, PhD
Jae Won Lee, MD, PhD
Department of Thoracic and
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Asan Medical Center
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MEMBRANE OXYGENATION
RESUSCITATION IN ADULT
PATIENTS WITH REFRACTORY
SEPTIC SHOCK
To the Editor:
We read the interesting report by
Huang and colleagues,1 in which
they described their experience using
extracorporeal membrane oxygena-
tion (ECMO) for adults with refrac-
tory septic shock. The investigatorsof Thoracic and Cardiovascular Surgerconclude that ECMO should not
be regarded as a rescue modality
in patients with refractory septic
shock, as highlighted by impaired
hemodynamics and progression of
inflammation-mediated organ failure.
The findings of profound shock and
multiple organ dysfunction among
these patients supported by ECMO,
despite appropriate antibiotics and
high-dose inotropes, redirect our
concern about a profound inflamma-
tory response, which possibly affects
their pharmacokinetics. Recently,
Angus and Van der Poll2 inferred
that proinflammatory reactions lead
to collateral tissue damage in severe
sepsis, and impaired tissue oxygena-
tion plays a vital role in organ
dysfunction. Moreover, it is well
known that venoarterial ECMO pro-
vides oxygenation and hemodynamic
stability, although it does not filter
the uncontrolled, circulating, acute in-
flammatory mediators that worsen tis-
sue damage.
Currently, extracorporeal blood pu-
rification therapies have been pro-
posed to limit these circulating
inflammatory mediators,3 but they do
not yet seem to be used in mainstream
clinical practice because of their prac-
tical and theoretic limitations. In our
experience,4 a combination of extra-
corporeal life support and plasma pu-
rification by resin adsorption has
been shown to play an important role
in the removal of proinflammatory cy-
tokines in the early phase of septic
shock, thereby preventing further he-
modynamic deterioration and
reducing the risk of multiple organ
dysfunction. In this ex vivo study,
the extracorporeal blood flow through
the resin adsorption filter was set at a
flow rate of 300 mL/min to achieve
higher single-pass clearance and
quantities of acute inflammatory me-
diators. The improvements in hemo-
dynamics were reflected in a
decrease in the mean pulmonary ar-
tery and central venous pressure, and
a concurrent increase in systemic
vascular resistance was observed iny c Volume 147, Number 4 1441
